Molina Healthcare (NYSE:MOH – Get Free Report) had its target price reduced by investment analysts at Wells Fargo & Company from $231.00 to $165.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of 14.58% from the stock’s previous close.
Several other brokerages also recently issued reports on MOH. Robert W. Baird decreased their target price on Molina Healthcare from $373.00 to $179.00 and set a “neutral” rating on the stock in a research note on Friday, July 25th. Wall Street Zen cut Molina Healthcare from a “hold” rating to a “sell” rating in a report on Saturday, October 25th. JPMorgan Chase & Co. reduced their price objective on shares of Molina Healthcare from $272.00 to $184.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 29th. The Goldman Sachs Group lowered their target price on shares of Molina Healthcare from $207.00 to $167.00 and set a “neutral” rating for the company in a research note on Friday, October 24th. Finally, Cantor Fitzgerald reduced their price objective on Molina Healthcare from $210.00 to $180.00 and set a “neutral” rating on the stock in a report on Friday, October 24th. Three analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $198.93.
Read Our Latest Stock Report on Molina Healthcare
Molina Healthcare Stock Performance
Molina Healthcare (NYSE:MOH – Get Free Report) last issued its quarterly earnings data on Wednesday, October 22nd. The company reported $1.84 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.97 by ($2.13). Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The business had revenue of $11.48 billion for the quarter, compared to the consensus estimate of $10.99 billion. During the same period in the previous year, the firm earned $6.01 EPS. The company’s revenue was up 11.0% on a year-over-year basis. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. Analysts anticipate that Molina Healthcare will post 24.4 EPS for the current year.
Institutional Investors Weigh In On Molina Healthcare
Large investors have recently bought and sold shares of the company. Aster Capital Management DIFC Ltd raised its position in Molina Healthcare by 613.9% during the third quarter. Aster Capital Management DIFC Ltd now owns 3,398 shares of the company’s stock valued at $650,000 after acquiring an additional 2,922 shares in the last quarter. Handelsbanken Fonder AB lifted its position in shares of Molina Healthcare by 11.4% in the third quarter. Handelsbanken Fonder AB now owns 14,637 shares of the company’s stock valued at $2,801,000 after acquiring an additional 1,500 shares in the last quarter. Choreo LLC grew its holdings in shares of Molina Healthcare by 176.0% during the third quarter. Choreo LLC now owns 2,752 shares of the company’s stock worth $527,000 after buying an additional 1,755 shares in the last quarter. Westpac Banking Corp lifted its stake in Molina Healthcare by 247.0% in the 3rd quarter. Westpac Banking Corp now owns 9,557 shares of the company’s stock worth $1,829,000 after purchasing an additional 6,803 shares in the last quarter. Finally, Amitell Capital Pte Ltd purchased a new stake in Molina Healthcare in the 3rd quarter valued at $7,290,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also
- Five stocks we like better than Molina Healthcare
- Financial Services Stocks Investing
- Rocket Lab Stock Jumps After Earnings, Despite Neutron Delay
- How to Most Effectively Use the MarketBeat Earnings Screener
- Occidental Petroleum is a Buy in Q4 2025
- Dividend Capture Strategy: What You Need to Know
- 3 Beaten-Down Stocks With Rebound Potential This Earnings Season
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
